Stay updated on Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Sign up to get notified when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows recruitment is closed with the message 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The revision label was updated to v3.6.0 from v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T12:34:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a minor software/UI update. It does not indicate changes to study content or data.
    Difference
    0.1%
    Check dated 2026-06-05T09:16:53.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.5.3 to v3.5.4, signaling a new version of the page. This metadata update does not modify the study details displayed.
    Difference
    0.1%
    Check dated 2026-05-15T04:19:33.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.5.2 to v3.5.3, reflecting a new release of the page's notes.
    Difference
    0.1%
    Check dated 2026-04-30T18:11:09.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Updated section/date details and refreshed link labels for study documents, including a “Redacted CSR Synopsis” and “Helpful Links” areas.
    Difference
    0.6%
    Check dated 2026-04-23T15:24:46.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:05:33.000Z thumbnail image

Stay in the know with updates to Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.